ABBV Earnings
AbbVie Inc. next reports earnings on October 29, 2026. Track record: 3/4 beats.
Next Earnings In
Thursday, October 29, 2026
Current Price
$250.94
EPS Estimate
Earnings Per Share
$3.84
+106.4% YoY
Trailing EPS
Last 12 months earnings
$3.54
Beat Rate
3/4
75%Forward P/E
Price-to-Earnings ratio
15.4
Margin: 9.8%
Analyst Rating
28 analysts
Analyst Sentiment
Buy28 analystsEarnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-06-30 | $3.61 | $3.65 | +1.1% | Beat |
| 2026-03-31 | $2.67 | $2.65 | -0.8% | Miss |
| 2025-12-31 | $2.65 | $2.71 | +2.2% | Beat |
| 2025-09-30 | $1.78 | $1.86 | +4.2% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $3.84 | $17.3B | +106.4% |
| Next Qtr(+1q) | $3.93 | $18.2B | +45.0% |
| Current Year(0y) | $14.09 | $67.6B | +40.9% |
| Next Year(+1y) | $16.29 | $73.1B | +15.6% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$3.84
Revenue Estimate
$17.3B
Annual EPS Est.
$14.09
+40.9% YoY
ABBV Earnings FAQ
When is ABBV's next earnings date?
AbbVie Inc. (ABBV) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $3.84.
Does ABBV usually beat earnings estimates?
AbbVie Inc. has beaten Wall Street EPS estimates in 3 of the last 4 quarters (75% beat rate).
What is ABBV's trailing EPS?
AbbVie Inc.'s trailing twelve-month EPS is $3.54. This is calculated from the last four quarters of reported earnings.
What do analysts think about ABBV?
28 Wall Street analysts cover AbbVie Inc.. The consensus rating is "Buy" with an average price target of $270.39, implying 7.8% upside from the current price.